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Abstract
Background: At a molecular level, insects utilize members of several highly divergent and unrelated families of cell-surface
chemosensory receptors for detection of volatile odorants. Most odors are detected via a family of odorant receptors (ORs),
which form heteromeric complexes consisting of a well-conserved OR co-receptor (Orco) ion channel and a non-conserved
tuning OR that provides coding specificity to each complex. Orco functions as a non-selective cation channel and is
expressed in the majority of olfactory receptor neurons (ORNs). As the destructive behaviors of many insects are principally
driven by olfaction, Orco represents a novel target for behavior-based control strategies. While many natural and synthetic
odorants have been shown to agonize Orco/Or complexes, only a single direct Orco modulator, VUAA1, has been described.
In an effort to identify additional Orco modulators, we have investigated the structure/activity relationships around VUAA1.
Results: A search of our compound library identified several VUAA1 analogs that were selected for evaluation against HEK
cells expressing Orco from the malaria vector Anopheles gambiae (AgOrco). While the majority of compounds displayed no
activity, many of these analogs possess no intrinsic efficacy, but instead, act as competitive VUAA1 antagonists. Using
calcium mobilization assays, patch clamp electrophysiology, and single sensillum in vivo recording, we demonstrate that
one such candidate, VU0183254, is a specific allosteric modulator of OR signaling, capable of broadly inhibiting odor-
mediated OR complex activation.
Conclusions: We have described and characterized the first Orco antagonist, that is capable of non-competitively inhibiting
odorant-evoked activation of OR complexes, thereby providing additional insight into the structure/function of this unique
family of ligand-gated ion channels. While Orco antagonists are likely to have limited utility in insect control programs, they
represent important pharmacological tools that will facilitate the investigation of the molecular mechanisms underlying
insect olfactory signal transduction.
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Introduction
Insect behavior is largely directed by the sensation of
environmental olfactory cues [1]. More important to human
health, the destructive behaviors of disease vector mosquitoes and
related dipterans are driven by the sensory modality of olfaction,
making it an important area of study [2]. AgOrs and other insect
ORs belong to a large and highly divergent superfamily, capable
of discerning a broad range of chemical odorants [3]. The breadth
and size of the OR family varies between insects, where these traits
combine to generate a remarkably diverse chemosensory reper-
toire [4]. Individual tuning AgORs are functionally defined by
their responses to various odorants, and these responses can vary
widely [5,6]. The OR co-receptor (Orco) is required for all OR-
based chemoreception in insects, which is the only lineage to
possess this unique and highly conserved ion channel that is
present in most ORNs [7,8,9]. Insect ORs are distinct from their
mammalian counterparts in that they are not related to any known
GPCRs and possess an inverse 7-TM topology [10,11]. Recently it
was shown that Orco is a non-selective cation channel, but it is
unclear what roles, if any, second messengers may play
[12,13,14,15]. In heterologous expression, Orco is capable of
forming functional channels independent of any tuning OR,
although the in vivo consequence of this capacity is unknown [14].
Tuning ORs expressed in the absence of Orco have no
demonstrable functional capacity in heterologous systems or in
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but also for trafficking of the OR complex to the ORN membrane
[7,8,10].
Classically, insect tuning ORs have been defined by their ability
to respond to various odorants, but always in complex with Orco.
In contrast, Orco does not have a defined natural ligand, and as a
result, its direct study has until recently not been possible. The first
Orco agonist, VUAA1, is a synthetic molecule that was discovered
in a chemical screen designed to identify AgOR modulators for
insect control with demonstrable activity in vivo [14]. In a
continuation of these studies, we sought to identify related
compounds in order to uncover more diversity within this novel
class of Orco modulators.
Results and Discussion
To better define the structure/activity relationships (SAR) of
VUAA1 analogs we performed calcium mobilization assays in
HEK cells expressing AgORs. While examining compounds in the
Vanderbilt Institute of Chemical Biology (VICB) collection that
shared structural similarities with VUAA1, a large number of
compounds were observed that possessed no intrinsic agonist
activity (data not shown). As a number of these compounds were
structurally related to VUAA1, we hypothesized that a subset of
these analogs may nevertheless have affinity for Orco, but lack
efficacy, and thus would be classically described as antagonists.
To investigate theseanalogs as VUAA1 antagonists,we examined
whether they were capable of suppressing VUAA1-mediated
responses of AgOrco-expressing HEK cells in calcium mobilization
assays [14]. In these competition experiments, we identified a
number of putative antagonists for further study (data not shown)
and chose to pursue two antagonists for further study based on their
differingefficaciesandstructuralcharacteristics.The firstantagonist,
VU0450667 is almost structurally identical to VUAA1, possessing
the same triazolopyridine core as VUAA1 and differing only in the
pattern of aniline substitution. A related analog, VU0183254,
possesses a furanotriazole core appended to a phenothiazine. It is
interesting to note that despite their similarity to VUAA1, they
possessed no agonist activity, demonstrating a narrow structure/
activity relationship of VUAA1-mediated Orco agonism.
When AgOrco was pre-treated with either of the two related
antagonists, VU0183254 or VU0450667, before VUAA1 addition,
theybothstronglyinhibitedVUAA1activationofOrco(Figure1A,B).
The IC50 values were 24.9+/20.09 and 22.8+/20.72 log M (+/
2SEM) for VU0183254 and VU0450667 respectively. We next
investigated whether these VUAA1 analogs were capable of
antagonizing odor-mediated activation of the Orco complex in the
same manner as above. Initially, to investigate the potential for non-
competitive antagonism of an Orco-Or complex, we chose AgOR65
as the tuning OR, which is potently agonized by eugenol [5,6].
Compound VU0183254 strongly antagonized odorant-mediated
activation of AgOrco-AgOr65 (IC50 24.8+/20.06 (LogM+/
2SEM)) (Figure 1C). Interestingly, although the 4-bromo-2-methy-
laniline-based amide analog of VUAA1 (VU0450667) acts as an
antagonist of VUAA1-mediated complex activation, it was virtually
incapable of inhibiting odor-mediated activation. This was unex-
pected and suggests these two molecules may be antagonists that act
via differing mechanisms.
To further examine the antagonist properties of VU0183254,
we tested AgOR complexes in HEK cells using whole-cell patch
clamp electrophysiology. When AgOrco+AgOr48 was treated
with the strong ligand delta-undecalactone, large macroscopic
currents were evoked that were reduced by 85.161.8% in the
Figure 1. VUAA1 analogs can antagonize AgOr responses. A. Structures of the Orco agonist VUAA1, Orco antagonist VU0183254, and control
VU0450667. B. IC50 curve of the response curves of AgOrco-only expressing HEK cells in the presence of pre-loaded antagonist (VU0183254 or
VU0450667) followed by an addition of VUAA1 to 100 mM; measurements were taken on an FDS6000 using Fluo4-AM as described in methods C. IC50
curve of AgOrco+AgOr65 expressing HEK cells as in B., followed by addition of eugenol to 1 mM.
doi:10.1371/journal.pone.0030304.g001
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currents of AgOrco-AgOr48 cells were similarly reduced
(85.561.5%) after VU0183254 treatment (Figure 2A). Another
AgOR complex, AgOrco+AgOr65, was also highly susceptible to
VU0183254 current reduction in the presence of both eugenol
(89.064.8%) and VUAA1 (85.063.5%) (Figure 2B). These results
validate and extend the calcium mobilization concentration
response curve (CRC) studies as well as demonstrate that
VU0183254 is a potent antagonist of both VUAA1 and odor-
mediated activation.
We next investigated whether VU0183254 is capable of acting
as a universal Orco antagonist or whether it is specific to AgOrco
by performing whole-cell patch clamp experiments in HEK cells
that transiently express Orco channels from the ponerine ant,
Harpegnathos saltator. When HsOrco, which is 62% identical to
AgOrco, was activated with VUAA1, VU0183254 reduced
VUAA1-mediated macroscopic currents by 63.962.2%. In these
assays, VU0183254 showed even stronger inhibition of VUAA1
currents (89.567.5%) from AgOrco-only expressing cells
(Figure 2C,D). These differences suggest that, despite the
conservation of Orco across insects, the potency of VU0183254
can vary across orthologous Orco channels. To test for specificity
of VU0183254 action, we examined its effect on the Rattus
norvegicus TRPV1 receptor, a nonselective cation channel unrelated
to the OR family [16]. Here, VU0183254 did not affect the
macroscopic currents induced by the natural TRPV1 ligand
capsaicin, although we note the natural desensitization of the
receptor in the presence of the agonist (Figure 2E). These results
demonstrate that VU0183254 does not act as a broad-spectrum
cation channel antagonist, although we cannot rule out effects on
other channel families beyond the scope of this study.
To determine the pharmacological nature of VU0183254-
mediated antagonism of both VUAA1 and odorant stimulation,
we examined the effect of VU0183254 treatment on AgOrco in
complex with the two odorant tuning AgOrs used above, AgOr48
and AgOr65. These tuning ORs are both narrowly tuned and are
15% identical, yet do not share any functional overlap [5,6]. These
ORs were chosen because of their disparate identities and ligand
specificities. In addition, the OR’s respective ligands elicit
responses at low nanomolar concentrations allowing CRCs to be
examined across a full range of responses. The effect of
VU0183254 was determined by pre-treating OR complexes with
antagonist, followed by agonist addition, such that multiple agonist
CRC’s were run in the presence of increasing concentrations of
pre-treated antagonist. When AgOrco+AgOr65 cells were pre-
treated with antagonist and then treated with eugenol, maximal
responses were depressed 70% compared to control. In addition,
curves were shifted dextrally as antagonist concentration was
increased (Figure 3A). In the absence of antagonist, the EC50 of
eugenol was found to be 26.69+/2.03 (LOGM+/2SEM),
whereas in the presence of 23.5LogM VU0183254, the EC50
was shifted to 25.286+/2.04(LOGM+/2SEM). Importantly,
these studies show the antagonism of VU0183254 was insur-
mountable; increasing concentrations of odorant agonist were
incapable of producing a maximal response equivalent to the no-
antagonist control. Furthermore, VU0183254 displayed insur-
mountable antagonism of AgOrco+AgOr48 stimulation by delta-
undecalactone (Figure 3C). These results are consistent with the
conclusion that VU0183254 acts as a broad-spectrum, non-
competitive antagonist against odorant-induced activation of
AgOrco+AgOr complexes.
It is important to note that for both receptor complexes,
antagonism becomes limited at 2100 mM. Despite increasing
concentrations of antagonist, further depressions in signal are not
seen. The mechanism of complete and insurmountable antago-
nism, such as was seen with odor-mediated antagonism of
AgOrco+AgOr65 and AgOrco+AgOr48, is non-competitive.
However, to define an insurmountable antagonist as allosteric, it
must be distinguished from a non-competitive orthosteric
antagonist [17]. When allosteric antagonists saturate a receptor
site, their antagonism becomes limited, such that further effects
cannot be elicited despite increasing concentrations of antagonist
[17]. The inhibition of odor-mediated activation of AgOrco+A-
gOr complexes by the VUAA1 analog VU0183254 is therefore
consistent with limited insurmountable antagonism, and is thus
classified as an allosteric antagonist.
We next examined the nature of VU0183254 antagonism of
VUAA1-mediatedagonism.Whentestedasabove,VU0183254was
also shown to depress VUAA1-mediated agonism of AgOrco+A-
gOr48 or AgOr65 cells (Figure 3B, D). Here, however, equimolar
antagonist concentrations were not nearly as effective in depressing
VUAA1 responses as they were odorant responses. The insolubility
of VUAA1 in assay buffer at concentrations greater than 100 mM
prevented testing at the concentrations required to assess whether
this antagonism was surmountable. However, the general trend
within this data is a dextral curve shift as antagonist concentration
increases, consistent with a competitive mode of antagonism. This
Figure 2. VU0183254 reduces OR-mediated currents. A–B.
Whole-cell patch clamp recordings of odorant- and VUAA1-induced
currents in AgOr-expressing cells (n=3). A. VU0183254 (100 mM)
decreased responses to delta-undecalactone (1 mM) and VUAA1
(100 mM) in HEK cells expressing AgOrco+AgOr48. B. Responses to
eugenol (1 mM) and VUAA1 (100 mM) in AgOrco+AgOr65 cells were
reduced by VU0183254 (100 mM). C–D. Cells expressing Orco from
either An. gambiae (C)o rHarpegnathos saltator (D) had reduced VUAA1
(100 mM) currents in the presence of 100 mM VU0183254. E. Capsaicin
(10 mM) currents in HEK cells expressing rat TRPVI were not reduced
with by 100 mM VU0183254. Holding potential for all figures is 260 mV.
doi:10.1371/journal.pone.0030304.g002
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and VUAA1, further supports a competitive mode of action for this
analoginsofarasVUAA1isconcerned.Takentogether,theseresults
provide strong support for the conclusion that VU0183254 acts a
competitive antagonist of VUAA1, but is a non-competitive,
allosteric antagonist of odor-mediated activation of OR complexes.
This conclusion is further supported by the data shown in Figure 1,
in which VU0450667 was largely incapable of inhibiting odor-
mediated activation, but VU0183254 was, whereas both were
capable of inhibiting VUAA1 activation. This probe dependence is
another indicator of allosteric modulation.
In order to assess the effect of VU0183254 on Orco-expressing
ORNs in vivo, we performed passive electrophysiological record-
ings on single capitate peg (Cp) sensilla of adult female mosquitoes.
Cp sensilla are found on the maxillary palps of An. gambiae and are
innervated by three olfactory receptor neurons in a highly
stereotyped pattern: CpB and CpC express Orco, while CpA is
narrowly tuned to CO2 and does not express Orco [18].
Observing the activity of these three neurons in a single-sensillum
recording (SSR) is accomplished by puncturing the sensillum with
a pulled-glass electrode and collectively sampling the activity of
CpA, B, and C neurons simultaneously. CpA spike activity can be
distinguished by its larger amplitude and its response to CO2 while
CpB and CpC spikes cannot be readily distinguished from each
other, and are consequently binned during analysis.
Previously, an increase in CpB/C activity was observed upon
treatment of Cp SSR preparations with the Orco agonist VUAA1
[14]. Based on its Orco antagonist activity, we introduced
VU0183254 to Cp sensilla via the recording pipette with the
expectation that the presence of this compound would reduce the
spontaneous firing rate of AgOrco-expressing CpB/C neurons
without affecting the activity of CpA. We based this expectation on
previous results demonstrating that in SSR assays using DmOrco
2/2
mutants of Drosophila melanogaster, ORN spontaneous activity is
significantly reduced [19]. In addition, exogenous expression of
different ORs in the Drosophila empty-neuron system, which is
DmOrco positive, but lacks other tuning ORs, results in varying
spontaneous activities [8]. Together, these data suggest that the
OR complex is responsible for determining the spontaneous
activity of ORNs and that an Orco antagonist would thus be
expected to reduce the spontaneous activity of these Orco-
containing neurons.
Palpal SSR studies were carried out in An. gambiae such that
spike activities were allowed to stabilize for 10 seconds in CO2–
free air following sensilla puncture, and then recorded for a period
of 60 seconds, followed by a pulse of CO2 to confirm CpA
sensitivity. Delivery of VU0183254 to treated Cp sensilla had no
effect on the spontaneous or CO2-evoked spike frequencies of the
CpA neuron (Figure 4A, B), but was indeed able to reduce the
spontaneous firing rate of CpB/C neurons in a dose-dependent
Figure 3. VU0183254 is an allosteric antagonist. A. Concentration response curves of AgOrco+AgOr65 expressing HEK cells in the presence of
a series of steady concentrations (expressed as logM) of pre-loaded VU0183254 (different colored lines, see inset) followed by increasing
concentrations of eugenol as measured using Fluo-4AM and an FDSS6000. B. As in A with VUAA1. C. As in A, with AgOrco+AgOr48 and delta-
undecalactone. D. As in C with VUAA1. In all cases results are shown as means+/2SEM, n=4.
doi:10.1371/journal.pone.0030304.g003
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VU0183254 is able to specifically antagonize spontaneous
AgOrco-mediated neuronal activity in vivo.
If VU0183254 is able to reduce the spontaneous activity of
CpB/C neurons by antagonizing Orco, we hypothesized that this
compound may also be able to antagonize odorant-mediated
activation of Orco-expressing ORNs in the Cp sensilla prepara-
tion. Indeed, CpB/C neurons exposed to recording solution with
solvent alone are strongly activated by the volatile odorant 1-
octen-3-ol (167.8+/234.1 spikes/s, N=11) (Figure 5A), but this
activation is strongly inhibited by the presence of VU0183254
(28.1+/24.98 spikes/s, N=11, p=0.0026) (Figure 5B). Taken
together, these results demonstrate that VU0183254 is capable of
suppressing passive ORN spontaneous activity as well as odor-
evoked activity. These studies further implicate AgOrco as the
principal facilitator of ORN spike activity.
Conclusion
These studies further our understanding of the nature of insect
OR-based signaling by demonstrating the existence of a universal
Orco–specific antagonist, which acts independently of odorant
stimulation. Because of Orco’s novelty relative to other ligand-
gated channels, and until recently the inability to study it directly
in the absence of an odorant-specific tuning OR, little is known
about its gating mechanisms. The identification of the VU0183254
antagonist provides new insight, in that it possesses affinity for the
Orco channel, most likely in the closed gating state. We suggest
that VU0183254 allosterically ‘‘locks’’ the channel shut, prevent-
ing odorants from orthosterically activating the channel complex.
Despite their potential utility in the study of insect OR signaling
mechanisms, there is little justification for the development of
Orco antagonists as insect control agents. The ability of Orco or
tuning OR antagonists to act as behavioral ‘‘confusants’’ is
compromised because, unlike laboratory studies involving unitary
odorant stimuli, most host/target organisms emit complex blends
of multiple semiochemicals that act as kairomones. Discrete
components of these chemical blends as well as other host-derived
stimuli are sensed in insects by ORs as well as OR-independent
signaling pathways that are mediated by other large families of
multi-modal cell-surface receptors [20,21,22] that are unlikely to
be affected by Orco/OR antagonists. In contrast, broad-spectrum
Orco agonists such as VUAA1 provide a more likely basis for the
development of a new generation of insect repellents, as they are
expected to act as excito-repellents that modulate insect behavior
by hyper-stimulation of sensory receptors resulting in aversive
behavioral responses.
While the molecular targets and mechanisms of most insect
repellents are not fully characterized, Citronella and DEET, two
of the most prevalent commercial agents, have both been
characterized as activators of AgOrco/OR complexes and
chemosensory neurons in several species [23,24,25,26,27]. Indeed,
recent studies in mosquitoes have demonstrated the utility of
Figure 4. VU0183254 reduces Orco-mediated activity in vivo. A. Representative traces of Cp neuron activity in response to vehicle (DMSO) or
VU0183254 as measured by single-sensillum electrophysiology. Activity was allowed to stabilize for 10 seconds and then recorded for 60 seconds.
CpA spikes can be distinguished by their larger amplitude in expansions (right panel). CpB/C spikes (counts below traces) are reduced in the presence
of VU0183254. B. Spontaneous CpA spike rates are unaffected by the presence of VU0183254 (n=8). Spikes were counted for each of the first
10 seconds and then averaged across the remaining 10-second intervals. Normal CpA activity is confirmed by CO2 pulse delivered at the end of the
recording period. C. Spontaneous firing rates of CpB/C neurons are reduced by VU0183254 in a dose-dependent manner (n=8). All spikes were
distinguished and quantified using AutoSpike software (Syntech).
doi:10.1371/journal.pone.0030304.g004
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[28]. While agonism of chemosensory receptors likely represents a
powerful insect control approach, DEET has also been implicated
in antagonism of some OR complexes, which further confounds its
mechanism of action [29,30]. While the ultimate utility of Orco
antagonists remains to be seen, their discovery and characteriza-
tion will serve as the foundation for the development of new
pharmacological tools that can be used to further interrogate the
novel channel class that insect ORs represent.
Methods
Cell Culture and Antagonist Testing
Creation of AgOr48 and AgOr65 HEK293 T-Rex (Invitrogen)
cell lines was carried out as described [14]. Calcium mobilization
assays were carried out essentially as described using Fluo4AM
(Invitrogen) chemistry and an FDSS6000 plate reader (Hamma-
matsu) [14,31]. Briefly, assay compounds were diluted in DMSO
to 100 mM and transferred to a 384-well, polypropylene Echo
Qualified Microplate (Labcyte) before being dispensed into 384-
well polypropylene destination plates (Greiner) using an
ECHO555 (Labcyte). Compounds were diluted in assay buffer
(20 mM HEPES, 16 Hanks Buffered Saline Solution) using a
Multidrop Combi (Thermo). To allow for antagonist equilibration,
antagonists were added to OR-expressing cells 100 s prior to
agonist addition. Fluorescence readings were taken at a frequency
of 1/s for the duration of each assay. Responses were quantified by
the ratio of the maximum fluorescent reading of a well divided by
the baseline reading of that well prior to antagonist addition.
Chemicals and VU0450667 synthesis. VU0183254,10-
({[4-ethyl-5-(2-furyl)-4H-1,2,4-triazol-3-yl]thio}acetyl)-10H-pheno-
thiazine was purchased from ChemBridge’s rare chemical library.
Delta-undecalactone and eugenol were purchased from Sigma-
Aldrich. VU0450667, N-(4-bromo-2-methylphenyl)-2-((4-ethyl-5-
(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide synthesis; To a
solution of 4-bromo-2-methylaniline (40.1 mg, 0.22 mmol) in
1.5 mL of CH2Cl2 was added triethyl amine (30 mL, 0.22 mmol)
and chloroacetyl chloride (17 mL, 0.22 mmol). After 2 h, the
solutionwasconcentrated thenredissolvedin1.5 mLofacetonitrile.
To this solution was added 4-ethyl-5-(pyridin-3-yl)-4H-1,2,4-
triazole-3-thiol (30 mg, 0.15 mmol) and cesium carbonate (98 mg,
0.3 mmol) After 16 h the reaction was concentrated and the residue
was purified by column chromatography with MeOH/CH2Cl2
(1:4) to afford 31 mg (50%) of the desired product:
1HN M R
(CDCl3) d 9.97 (s, 1H), 8.85 (s, 1H), 8.78 (d, J=3.3 Hz, 1H), 7.95
(dt, J=1.8, 7.9 Hz, 1H), 7.91 (d, J=9.3 Hz, 1H), 7.48 (dd, J=4.9,
7.8 Hz, 2H), 7.29 (m, 2H), 4.07 (s, 2H), 4.00 (dd, J=7.3, 14.5 Hz,
2H), 2.33 (s, 3H), 1.39 (t, 7.3 Hz, 3H); LRMS calculated for
C18H18BrN5OS (M+H)
+ m/z: 432.0 Measured 432.0 m/z.
Single Sensillum Recording. Recordings from 5–6 day-old
female An. gambiae mosquitoes were performed as described
previously ([14]). Statistical analysis consisted of Student’s t-tests
performed using Prism software (Graphpad).
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